<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药投资并购俱乐部 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-24T20:32:34+08:00</updated>
  <subtitle>healthib俱乐部是医药医疗健康领域企业家与投资人的资源共享与价值共创的非营利性公众学习平台，专注于投资并购与产业整合资源的分享和学习，感谢您的关注！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年中国双特异性抗体行业投资机会分析</title>
    <updated>2020-12-24T17:20:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/LLC8KMkoNf4agKZw2l2QEQ</id>
    <link href="https://mp.weixin.qq.com/s/LLC8KMkoNf4agKZw2l2QEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医疗保健行业研究报告：内镜观察系列2（诊疗器械）深度报告-聚焦高端品类，着眼全球发展</title>
    <updated>2020-12-23T15:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ISL6YilAnqQzXKgkdJbPEA</id>
    <link href="https://mp.weixin.qq.com/s/ISL6YilAnqQzXKgkdJbPEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医疗保健行业：内镜观察系列1深度报告-内窥镜：国产替代浪潮下砥砺前行</title>
    <updated>2020-12-22T15:53:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/qmaGOrb2-3ZV60nhK7np3Q</id>
    <link href="https://mp.weixin.qq.com/s/qmaGOrb2-3ZV60nhK7np3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他氟前列素——最出色青光眼药物之一（下）</title>
    <updated>2020-12-21T13:29:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/3eyu87rkTjYD6ItpUzuCEA</id>
    <link href="https://mp.weixin.qq.com/s/3eyu87rkTjYD6ItpUzuCEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他氟前列素——最出色青光眼药物之一（上）</title>
    <updated>2020-12-18T10:09:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/NULmAj9-9knH9qO8QQCoDQ</id>
    <link href="https://mp.weixin.qq.com/s/NULmAj9-9knH9qO8QQCoDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他氟前列素滴眼液治疗引起上眼睑沟加深的发生率增高</title>
    <updated>2020-12-17T15:55:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/jAM4bblCU2A1HkQVdQQeWg</id>
    <link href="https://mp.weixin.qq.com/s/jAM4bblCU2A1HkQVdQQeWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年医药生物行业策略报告：聚焦黄金赛道，寻找疫后高光</title>
    <updated>2020-12-16T15:42:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/qYT1ce2v7M8RzwTbrGSKKQ</id>
    <link href="https://mp.weixin.qq.com/s/qYT1ce2v7M8RzwTbrGSKKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>日本器械如何突围医保压力对国内集采控费下医疗器械行业发展的借鉴经验</title>
    <updated>2020-12-15T16:26:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/JQMXczF67bV7ZH9UypRyaQ</id>
    <link href="https://mp.weixin.qq.com/s/JQMXczF67bV7ZH9UypRyaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药生物行业周报：2021医药“春季躁动”有望提前到来，关注医药消费投资机会</title>
    <updated>2020-12-14T16:32:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/MO_Lh7qY6eCrMZ_xBp-cSA</id>
    <link href="https://mp.weixin.qq.com/s/MO_Lh7qY6eCrMZ_xBp-cSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国脱敏治疗行业短报告</title>
    <updated>2020-12-11T15:07:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/ffa2QByGGyIBa0KL7YpyQg</id>
    <link href="https://mp.weixin.qq.com/s/ffa2QByGGyIBa0KL7YpyQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>